Literature DB >> 18353497

Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.

C T Moor1, S A Roberts, G Simmons, S Briggs, A J Morris, J Smith, H Heffernan.   

Abstract

We aimed to document the epidemiology of extended-spectrum beta-lactamase (ESBL)-producing enterobacteria in the Auckland community and identify factors associated with infection using a case-control study design. ESBL-producing enterobacteria were isolated from 107 infected patients, for which demographic and clinical data were available for 98 cases (92%). Escherichia coli was the predominant organism (82%), with urine as the commonest source (97%). Compared with a control group infected with ESBL-negative enterobacteria, factors significantly associated with infection on univariate analysis were: living in a residential care home (RCH); recent admission to hospital 'M'; recent antibiotic use; older age (>75 years); presence of a urinary catheter; and a history of comorbid chronic obstructive pulmonary disease (COPD), cardiovascular disease, neurological disease or recurrent urinary tract infection. On multivariate analysis, residence in RCH and COPD remained significant associations. Pulsed-field gel electrophoresis typing of the ESBL-producing E. coli identified a common strain. We concluded that residence in RCH and a history of COPD are significant associations with ESBL-producing enterobacterial infection in the Auckland community. Several spatial clusters in RCHs and a common strain suggest point-source outbreaks. A substantial number of community cases did not live in an RCH nor had been recently hospitalised, suggesting the independent generation of ESBL-producing enterobacteria in the broader community.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353497     DOI: 10.1016/j.jhin.2008.02.003

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  10 in total

1.  Bacteremia caused by extended-spectrum-β-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality.

Authors:  Hsing-Chun Chung; Chung-Hsu Lai; Jiun-Nong Lin; Chun-Kai Huang; Shiou-Haur Liang; Wei-Fang Chen; Yi-Chun Shih; Hsi-Hsun Lin; Jiun-Ling Wang
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

2.  Community-associated extended-spectrum β-lactamase-producing Escherichia coli infection in the United States.

Authors:  Yohei Doi; Yoon Soo Park; Jesabel I Rivera; Jennifer M Adams-Haduch; Ameet Hingwe; Emilia M Sordillo; James S Lewis; Wanita J Howard; Laura E Johnson; Bruce Polsky; James H Jorgensen; Sandra S Richter; Kathleen A Shutt; David L Paterson
Journal:  Clin Infect Dis       Date:  2012-11-13       Impact factor: 9.079

3.  Urinary tract infection in infants caused by extended-spectrum beta-lactamase-producing Escherichia coli: comparison between urban and rural hospitals.

Authors:  Ming-Fang Cheng; Wan-Ling Chen; I-Fei Huang; Jung-Ren Chen; Yee-Hsuan Chiou; Yao-Shen Chen; Susan Shin-Jung Lee; Wan-Yu Hung; Chih-Hsin Hung; Jiun-Ling Wang
Journal:  Pediatr Nephrol       Date:  2016-03-14       Impact factor: 3.714

4.  Clinical and Molecular Characterization of Community-Onset Urinary Tract Infections Due to Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae.

Authors:  Judith A Anesi; Ebbing Lautenbach; Irving Nachamkin; Charles Garrigan; Warren B Bilker; Mary Wheeler; Pam Tolomeo; Jennifer H Han
Journal:  Infect Control Hosp Epidemiol       Date:  2016-09-28       Impact factor: 3.254

5.  Clinical patterns, epidemiology and risk factors of community-acquired urinary tract infection caused by extended-spectrum beta-lactamase producers: a prospective hospital case-control study.

Authors:  Basima A Almomani; Wail A Hayajneh; Abeer M Ayoub; Mera A Ababneh; Miral A Al Momani
Journal:  Infection       Date:  2018-05-10       Impact factor: 3.553

6.  Patient's origin and lifestyle associated with CTX-M-producing Escherichia coli: a case-control-control study.

Authors:  Marie-Hélène Nicolas-Chanoine; Vincent Jarlier; Jérôme Robert; Guillaume Arlet; Laurence Drieux; Véronique Leflon-Guibout; Cédric Laouénan; Béatrice Larroque; Valérie Caro; France Mentré
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

7.  Differences in risk-factor profiles between patients with ESBL-producing Escherichia coli and Klebsiella pneumoniae: a multicentre case-case comparison study.

Authors:  Joshua T Freeman; Joseph Rubin; Gary N McAuliffe; Gisele Peirano; Sally A Roberts; Dragana Drinković; Johann Dd Pitout
Journal:  Antimicrob Resist Infect Control       Date:  2014-09-01       Impact factor: 4.887

8.  Community-Onset Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France.

Authors:  Julie Toubiana; Sandra Timsit; Agnès Ferroni; Marie Grasseau; Xavier Nassif; Olivier Lortholary; Jean-Ralph Zahar; Martin Chalumeau
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

9.  Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.

Authors:  Arne Søraas; Arnfinn Sundsfjord; Irene Sandven; Cathrine Brunborg; Pål A Jenum
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

10.  Health care workers' mobile phones: a potential cause of microbial cross-contamination between hospitals and community.

Authors:  Cemal Ustun; Mustafa Cihangiroglu
Journal:  J Occup Environ Hyg       Date:  2012       Impact factor: 2.155

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.